journal article·2025-10Open access

Near-infrared-triggered copper-doped carbon nitride nanocomposite inducing domino effect for synergistic tumor therapy and immune microenvironment reprogramming

Xiaoqian Zhang, Guanhua Qiu, Yuanyuan Chen, Sida Wang, Chuangye Han, Shutian Mo, Junjie Liu, Duo Wang, Zisan Zeng

Abstract

Multimodal targeted combination therapies harnessing synergistic interactions have emerged as a transformative paradigm in oncology, gradually superseding conventional monotherapies. We herein report a near-infrared (NIR) light-triggered multifunctional nanocomposite based on copper-doped graphitic-phase carbon nitride (named CNCu@HA), which efficiently eliminates tumors by inducing apoptosis, cuproptosis, and immunogenic cell death (ICD) while initiating robust immune responses. Specifically, the incorporation of copper ions enhances NIR photoabsorption and effectively separates the electron-hole pairs. Moreover, copper ions exhibit Fenton-like reaction capabilities. Consequently, the triggered domino effect of CNCu@HA not only achieves photothermal ablation of tumor cells but also functions as a dual Fenton-like catalyst and photosensitizer, generating excessive reactive oxygen species (ROS) and depleting glutathione (GSH). This process enhances the synergistic efficacy of chemodynamic therapy (CDT) and photodynamic therapy (PDT), promoting tumor cell apoptosis. The resultant intracellular oxidative stress overload impairs mitochondrial function, downregulates ATP levels, and suppresses ATP-dependent heat shock proteins expression, thereby synchronously augmenting the therapeutic effect of mild photothermal therapy (mPTT). Additionally, reduced ATP levels impede copper ion efflux, leading to intracellular copper ions accumulation. Cu 2+ react with endogenous hydrogen peroxide (H 2 O 2 ) to produce O 2 and Cu + , alleviating intratumoral hypoxia and increasing cancer cell susceptibility to cuproptosis. These CNCu@HA-induced cytotoxic effects trigger ICD-driven dendritic cell maturation, M1 macrophage polarization, and CD8 + T cell infiltration. This process activates a multilayered cascade of synergistic interactions, potentiating the immune response, reshaping the tumor immune microenvironment, and achieving a domino therapeutic effect, demonstrating remarkable antitumor efficacy in both in vitro and in vivo models.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Adenosine and Purinergic Signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (73)

Show source-provided references
1. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2. Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma A review10.1001/jamaoncol.2023.2677 ↗
3. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives10.1186/s13045-024-01549-2 ↗
4. Overcoming cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges10.1016/j.biopha.2023.114643 ↗
5. Subcellular performance of nanoparticles in cancer therapy10.2147/IJN.S226186 ↗
6. Imaging guided endogenic H2-Augmented Electrochemo-Sonodynamic domino Co-therapy of tumor in vivo10.1002/adma.202208414 ↗
7. Cascade-responsive nanobomb with domino effect for anti-tumor synergistic therapies10.1093/nsr/nwab139 ↗
8. Developing hypoxia-sensitive system via designing tumor-targeted fullerene-based photosensitizer for multimodal therapy of deep tumor10.1002/adma.202310875 ↗
9. Smart nanoassembly enabling activatable NIR fluorescence and ROS generation with enhanced tumor penetration for imaging-guided photodynamic therapy10.1002/adma.202404296 ↗
10. Expanded ROS generation and hypoxia reversal: excipient-free self-assembled nanotheranostics for enhanced cancer photodynamic immunotherapy10.1002/adma.202402720 ↗
11. 2D Architectures-transformed conformational nanoarchitectonics for light-augmented nanocatalytic chemodynamic and Photothermal/Photodynamic-based trimodal therapies10.1021/acsmaterialslett.3c01615 ↗
12. Interstitial optical fiber-mediated multimodal phototheranostics based on an aggregation-induced NIR-II emission luminogen for orthotopic breast cancer treatment10.1002/adma.202406474 ↗
13. Targeting ROS in cancer: rationale and strategies10.1038/s41573-024-00979-4 ↗
14. NIR-II AIE liposomes for boosting Type-I photodynamic and mild-temperature photothermal therapy in breast cancer treatment10.1002/adma.202411133 ↗
15. A bioinspired photosensitizer performs tumor thermoresistance reversion to optimize the atraumatic mild-hyperthermia photothermal therapy for breast cancer10.1002/adma.202405890 ↗
16. A multifunctional nanocatalytic metal-organic framework as a ferroptosis amplifier for mild hyperthermia photothermal therapy10.34133/research.0397 ↗
17. Plasma membrane targeted photodynamic nanoagonist to potentiate immune checkpoint blockade therapy by initiating tumor cell pyroptosis and depleting infiltrating B cells10.1002/adma.202415078 ↗
18. A light-triggered J-Aggregation-Regulated therapy conversion: from Photodynamic/Photothermal therapy to long-lasting chemodynamic therapy for effective tumor ablation10.1002/anie.202404395 ↗
19. Defect engineering in polymeric carbon nitride photocatalyst: synthesis, properties and characterizations10.1016/j.cis.2021.102523 ↗
20. Single atom iron-doped graphic-phase C3N4 semiconductor nanosheets for augmented sonodynamic melanoma therapy synergy with endowed chemodynamic effect10.1002/advs.202302579 ↗
21. Decade milestone advancement of defect-engineered g-C3N4 for solar catalytic applications10.1007/s40820-023-01297-x ↗
22. Monolayer graphitic carbon nitride as metal-free catalyst with enhanced performance in Photo- and Electro-Catalysis10.1007/s40820-022-00794-9 ↗
23. Dual-Defect regulated G-C3N4 for piezoelectric catalytic tumor therapy with enhanced efficacy10.1002/adma.202412069 ↗
24. Photodynamic therapy: when van der Waals heterojunction meets tumor10.1016/j.cej.2021.129773 ↗
25. Cu-coated graphitic carbon nitride (Cu/CN) with ideal photocatalytic and antibacterial properties10.1016/j.cartre.2023.100307 ↗
26. Modulating dual carrier-transfer channels and band structure in carbon nitride to amplify ROS storm for enhanced cancer photodynamic therapy
27. Ruthenium(II) complexes coordinated to graphitic carbon nitride: oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia10.1016/j.biomaterials.2021.121064 ↗
28. Strategies to engineer various nanocarrier-based hybrid catalysts for enhanced chemodynamic cancer therapy10.1039/D3CS00356F ↗
29. Manipulating intratumoral fenton chemistry for enhanced chemodynamic and chemodynamic-synergized multimodal therapy10.1002/adma.202104223 ↗
30. Overcoming multidrug resistance through the synergistic effects of hierarchical pH-Sensitive, ROS-Generating nanoreactors10.1021/acsbiomaterials.7b00569 ↗
31. Ultrathin 2D Copper(I) 1,2,4-Triazolate coordination polymer nanosheets for efficient and selective gene silencing and photodynamic therapy10.1002/adma.202100849 ↗
32. Double-Layered hollow mesoporous cuprous oxide nanoparticles for double drug sequential therapy of tumors10.1002/adma.202313212 ↗
33. Copper-based metal-organic framework overcomes CancerChemoresistance through systemically disrupting DynamicallyBalanced cellular redox homeostasis10.1021/jacs.1c11856 ↗
34. Transition metal oxide-decorated MXenes as drugless nanoarchitectonics for enriched nanocatalytic chemodynamic treatment10.1002/adhm.202303582 ↗
35. Copper induces cell death by targeting lipoylated TCA cycle proteins10.1126/science.abf0529 ↗
36. Targeting cuproplasia and cuproptosis in cancer10.1038/s41571-024-00876-0 ↗
37. Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated anti- tumor immunity in colorectal cancer10.1016/j.mattod.2023.06.024 ↗
38. A vacancy-engineering ferroelectric nanomedicine for Cuproptosis/Apoptosis Co-Activated immunotherapy10.1002/adma.202403253 ↗
39. Self-Destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors10.1002/adma.202308241 ↗
40. Glutathione-scavenging Celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy10.1002/adma.202404971 ↗
41. A self-amplifying ROS-Responsive nanoplatform for simultaneous cuproptosis and cancer immunotherapy10.1002/advs.202401047 ↗
42. Macrocyclic supramolecular assemblies based on hyaluronic acid and their biological applications10.1021/acs.accounts.2c00462 ↗
43. Recent advances in hyaluronic acid-based nanomedicines: preparation and application in cancer therapy10.1016/j.carbpol.2022.119662 ↗
44. Hyaluronan as tunable drug delivery system10.1016/j.addr.2019.08.006 ↗
45. Nanoarchitectured hyaluronic acid-decorated hierarchical drug-like assemblies as synergistic immune modulators against breast carcinoma10.1016/j.ijbiomac.2025.143271 ↗
46. Engineering naphthalimide-cyanine integrated near-infrared dye into ROS-responsive nanohybrids for tumor PDT/PTT/chemotherapy
47. Single-Atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy10.1002/anie.202101924 ↗
48. Cu single atom nanozyme based high-efficiency mild photothermal therapy through cellular metabolic regulation10.1002/anie.202209245 ↗
49. Extracellular Matrix Viscosity Reprogramming by In Situ Au Bioreactor-Boosted Microwavegenetics Disables Tumor Escape in CAR-T Immunotherapy10.1021/acsnano.2c10845 ↗
50. Macrophage-inherited exosome excise tumor immunosuppression to expedite immune-activated ferroptosis10.1136/jitc-2022-006516 ↗
51. Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity10.1016/j.jconrel.2024.06.052 ↗
52. Copper(II)-Graphitic Carbon Nitride triggered synergy: improved ROS generation and reduced glutathione levels for enhanced photodynamic therapy10.1002/anie.201605509 ↗
53. Copper-Loaded nanoheterojunction enables superb orthotopic Osteosarcoma therapy via oxidative stress and cell cuproptosis10.1021/acsnano.3c04903 ↗
54. One-pot synthesized nano-heterostructure with dual-modal catalytic ROS generation ability for high-metastatic orthotopic osteosarcoma therapy10.1016/j.carbon.2022.12.053 ↗
55. Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system10.1016/j.jconrel.2018.04.015 ↗
56. In-situ fabrication of novel Au nanoclusters-Cu2+@sodium alginate/hyaluronic acid nanohybrid gels for cuproptosis enhanced photothermal/photodynamic/chemodynamic therapy via tumor microenvironment regulation10.1016/j.jcis.2023.03.065 ↗
57. Mitochondria and Nuclei dual-targeted hollow carbon nanospheres for cancer chemophotodynamic synergistic therapy10.1021/acs.molpharmaceut.9b00259 ↗
58. Degradation of structurally defined graphene nanoribbons by myeloperoxidase and the photo-fenton reaction10.1002/anie.202008925 ↗
59. Biological degradation of graphitic carbon nitride sheets and autophagy induction in macrophages
60. Carbon-Dot-Decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting10.1021/acsnano.6b04156 ↗
61. A bioinspired hollow g-C3N4-CuPc heterostructure with remarkable SERS enhancement and photosynthesis-mimicking properties for theranostic applications10.1039/D2SC01534J ↗
62. MnOOH-Catalyzed Autoxidation of glutathione for reactive oxygen species production and Nanocatalytic Tumor Innate immunotherapy (vol 145, pg 5803, 2023)10.1021/jacs.3c03717 ↗
63. Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response10.1186/s12951-024-02809-6 ↗
64. Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and cuproptosis10.1016/j.redox.2024.103260 ↗
65. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based synergistic cancer Therapy (vol 35, year 2023, page 1)10.1002/adma.202300773 ↗
66. Harnessing bimetallic iMWA nanosensitizer to unleash ferroptosis and calcium overload: unlocking tumor vulnerability for potentiated iMWA therapy against hepatocellular carcinoma10.1016/j.cej.2024.153368 ↗
67. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications10.1186/s12967-023-04533-5 ↗
68. Cuproptosis induced by ROS responsive nanoparticles with Elesclomol and copper combined with αPD-L1 for enhanced cancer immunotherapy
69. Intraparticle double-scattering-decoded sonogenetics for augmenting immune checkpoint blockade and CAR-T therapy10.1002/advs.202203106 ↗
70. Therapeutic hydrogel for enhanced immunotherapy: a powerful combination of MnO2 nanosheets and vascular disruption10.1016/j.nantod.2022.101673 ↗
71. Multichannel sonocatalysis amplifiers target IDH1-Mutated tumor plasticity and attenuate Ros tolerance to repress malignant cholangiocarcinoma
72. Metal-Cyclic dinucleotide nanomodulator-stimulated STING signaling for strengthened radioimmunotherapy of large tumor
73. Plasmonic-doped melanin-mimic for CXCR4-targeted NIR-II photoacoustic computed tomography-guided photothermal ablation of orthotopic hepatocellular carcinoma10.1016/j.actbio.2021.05.034 ↗